Is This U.S. Pot Stock the New Industry Leader?

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) may have been the dominant name in the cannabis industry thus far, but that might not be the case for much longer.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Canopy Growth has tried to assert itself atop the cannabis industry in North America. It made a lot of aggressive moves to try and give itself and its investors a lot of potential growth to benefit from in the years ahead.

From locking in a big investor like Constellation Brands to getting a deal in place with Acreage Holdings, the company has made numerous moves to help position itself for success.

Access to U.S. market critical for long-term growth

The problem is that even if investors think Canopy Growth is a good investment, it’s inherently limited. Being restricted to the Canadian market and only being able to sell hemp-based products in the U.S. (for now) has put a limit on to just how much growth the company can achieve in the near future.

Even if the U.S. moves to legalize marijuana, that’s likely not going to happen anytime soon. That’s why Canopy Growth was always going to be a long shot to be the biggest cannabis brand, simply because it didn’t have access to the biggest cannabis market.

Multi-state operator Curaleaf Holdings (CNSX:CURA), however, doesn’t have those same obstacles. With the company not being on the TSX and based in the U.S., Curaleaf has a lot more flexibility in what it can do. And while federally there are still significant challenges, growing via acquisition is one way that the company can expand into other parts of the country, which is what it has done.

This week, Curaleaf released its second-quarter results. Its US$48 million in revenue during the quarter was a 231% improvement from the prior year. On a pro-forma basis, including the company’s acquisitions and assuming they had been completed on January 1, that number soars to US$110.9 million, which would dwarf what we’ve seen thus far from Canadian producers.

The company also reached a milestone on its bottom line as well, posting a positive adjusted EBITDA figure of US$3.4 million for the first time in its history. This was an improvement from the prior year when it incurred a loss of US$3.8 million.

Currently, through acquisitions, Curaleaf now has access to 19 states. With some big acquisitions under its belt already, the company is still expecting even more growth down the road.

In its earnings release, Curaleaf CEO Joseph Lusardi stated, “The recently announced acquisitions of Select and Grassroots, as well as, tuck in acquisitions in ArizonaCalifornia, Nevada, and Ohio position Curaleaf as the undisputed leader in the cannabis industry. With the industry’s largest operational footprint, we have the scale to rapidly accelerate growth across the country.”

More states looking to legalize pot

Thus far, we’ve seen 11 states in the U.S. legalize marijuana for recreational use. However, we could see that number grow, as both New York and New Jersey are two states that have shown interest in legalization, and other states are trying to get marijuana legalization on the ballot for 2020.

With more markets potentially becoming available, the growth potential for Curaleaf could get bigger very soon. For Canopy Growth, its path is not quite as clear.

Should you invest $1,000 in Royal Bank of Canada right now?

Before you buy stock in Royal Bank of Canada, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Royal Bank of Canada wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »